A novel type of cellular senescence that can be enhanced in mouse models and human tumor xenografts to suppress prostate tumorigenesis
Open accessThe DOI matches its Crossref record; 46 of the 46 references it cites were found in a registry or an index.
Abstract
Irreversible cell growth arrest, a process termed cellular senescence, is emerging as an intrinsic tumor suppressive mechanism. Oncogene-induced senescence is thought to be invariably preceded by hyperproliferation, aberrant replication, and activation of a DNA damage checkpoint response (DDR), rendering therapeutic enhancement of this process unsuitable for cancer treatment. We previously demonstrated in a mouse model of prostate cancer that inactivation of the tumor suppressor phosphatase and tensin homolog deleted on chromosome 10 (Pten) elicits a senescence response that opposes tumorigenesis. Here, we show that Pten-loss-induced cellular senescence (PICS) represents a senescence response that is distinct from oncogene-induced senescence and can be targeted for cancer therapy. Using mouse embryonic fibroblasts, we determined that PICS occurs rapidly after Pten inactivation, in the absence of cellular proliferation and DDR. Further, we found that PICS is associated with enhanced p53 translation. Consistent with these data, we showed that in mice p53-stabilizing drugs potentiated PICS and its tumor suppressive potential. Importantly, we demonstrated that pharmacological inhibition of PTEN drives senescence and inhibits tumorigenesis in vivo in a human xenograft model of prostate cancer. Taken together, our data identify a type of cellular senescence that can be triggered in nonproliferating cells in the absence of DNA damage, which we believe will be useful for developing a "pro-senescence" approach for cancer prevention and therapy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Although initially PTEN loss-induced cellular senescence was not associated with DDR activation40, it was later found to be associated with hyperproliferation, DDR engagement and cellular senescence in vivo41”
From Cellular senescence in ageing: from mechanisms to therapeutic opportunities (2021) · cites this paper as [40]
The cited source says what the claim attributes to it.
In the citing paper
“However, despite this, DDR markers have a limited potential for identifying senescent cells in vivo since DDR independent mechanisms are also capable of inducing senescence via p53/p21WAF1/CIP1 pathway (Alimonti et al., 2010; Freund et al., 2011; Muñoz-Espín et al., 2013; Storer et al., 2013; Salama et al., 2014).”
From Mechanisms of Cellular Senescence: Cell Cycle Arrest and Senescence Associated Secretory Phenotype (2021) · cites this paper as Alimonti et al., 2010
The cited source says what the claim attributes to it.
In the citing paper
“pharmacological inhibition of PTEN in prostate cancer that is wild type for TP53, results in the inhibition of tumorigenesis with senescence induction in a human xenograft model 152”
From Inside and out: the activities of senescence in cancer (2014) · cites this paper as [152]
The cited source says what the claim attributes to it.
In the citing paper
“TP53 up-regulation upon PTEN inhibition appears to be dependent on mTOR activity, which increases TP53 translation 152”
From Inside and out: the activities of senescence in cancer (2014) · cites this paper as [152]
The cited source says what the claim attributes to it.
In the citing paper
“unlike OIS, PICS occurs in the absence of transient hyper-proliferation and a DNA damage response (DDR) 152”
From Inside and out: the activities of senescence in cancer (2014) · cites this paper as [152]
4 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Small molecule–based reversible reprogramming of cellular lifespan
Won, J., Kim, M. K., Kim, N., Ahn, J. H., Lee, W. G., Kim, S. S., Chang, K.-Y., Yi, Y.-W., & Kim, T. K. (2006) · Nature Chemical Biology · doi:10.1038/nchembio800 · Cited by 74
RetractedJemal, A., Siegel, R., Ward, E., Murray, T., Xu, J., & Thun, M. J. (2007) · CA: A Cancer Journal for Clinicians · doi:10.3322/canjclin.57.1.43 · Cited by 7,439
Li, J., Yen, C., Liaw, D., Podsypanina, K., Bose, S., Wang, S. I., Puc, J., Miliaresis, C., Rodgers, L., McCombie, R., et al. (1997) · Science · doi:10.1126/science.275.5308.1943 · Cited by 4,785
In Vivo Activation of the p53 Pathway by Small-Molecule Antagonists of MDM2
Vassilev, L. T., Vu, B. T., Graves, B., Carvajal, D., Podlaski, F., Filipovic, Z., Kong, N., Kammlott, U., Lukacs, C., Klein, C., et al. (2004) · Science · doi:10.1126/science.1092472 · Cited by 4,661
Tumour stem cells and drug resistance
Dean, M., Fojo, T., & Bates, S. (2005) · Nature reviews. Cancer · doi:10.1038/nrc1590 · Cited by 3,668
Cancer stem cells in solid tumours: accumulating evidence and unresolved questions
Visvader, J. E., & Lindeman, G. J. (2008) · Nature Reviews Cancer · doi:10.1038/nrc2499 · Cited by 3,429
Maehama, T., & Dixon, J. E. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.22.13375 · Cited by 3,104
Steck, P. A., Pershouse, M. A., Jasser, S. A., Yung, W. K. A., Lin, H., Ligon, A. H., Langford, L. A., Baumgard, M. L., Hattier, T., Davis, T., et al. (1997) · Nature Genetics · doi:10.1038/ng0497-356 · Cited by 2,741
DNA damage response as a candidate anti-cancer barrier in early human tumorigenesis
Bartkova, J., Hořejší, Z., Koed, K., Krämer, A., Tort, F., Zieger, K., Guldberg, P., Sehested, M., Nesland, J. M., Lukas, C., et al. (2005) · Nature · doi:10.1038/nature03482 · Cited by 2,688
Negative regulation of PKB/Akt-dependent cell survival by the tumor suppressor PTEN
Stambolic, V., Suzuki, A., de la Pompa, J. L., Brothers, G. M., Mirtsos, C., Sasaki, T., Ruland, J., Penninger, J. M., Siderovski, D. P., & Mak, T. W. (1998) · Cell · doi:10.1016/s0092-8674(00)81780-8 · Cited by 2,551
Cited by
Items 201–300 of 372
Proteomic and transcriptomic profiling of Pten gene‐knockout mouse model of prostate cancer
Zhang, J., Kim, S., Li, L., Kemp, C. J., Jiang, C., & Lü, J. (2020) · The Prostate · doi:10.1002/pros.23972 · Cited by 26
Novel ARF/p53-independent senescence pathways in cancer repression
Chan, C., Gao, Y., Moten, A., & Lin, H. (2011) · Journal of Molecular Medicine · doi:10.1007/s00109-011-0766-y · Cited by 29
The impact of cellular senescence in cancer therapy: is it true or not?
Zhang, Y., & Yang, J. (2011) · Acta Pharmacologica Sinica · doi:10.1038/aps.2011.108 · Cited by 30
Loss of the ubiquitin conjugating enzyme UBE2E3 induces cellular senescence
Plafker, K. S., Zyla, K., Berry, W. L., & Plafker, S. M. (2018) · Redox Biology · doi:10.1016/j.redox.2018.05.008 · Cited by 26
Autophagy and PTEN in DNA damage-induced senescence
Sharma, A., & Almasan, A. (2021) · Advances in cancer research · doi:10.1016/bs.acr.2021.01.006 · Cited by 29
Wang, Y., Xu, Q., Sack, L. M., Kang, C., & Elledge, S. J. (2016) · Genes & Development · doi:10.1101/gad.271445.115 · Cited by 24
The roles of MTOR and miRNAs in endothelial cell senescence
Khor, E.-S., & Wong, P. (2020) · Biogerontology · doi:10.1007/s10522-020-09876-w · Cited by 24
The Dynamic Process and Its Dual Effects on Tumors of Therapy-Induced Senescence
Liao, C., Xiao, Y., & Liu, L. (2020) · Cancer Management and Research · doi:10.2147/cmar.s285083 · Cited by 26
Wang, L., Guo, X., Wang, J., Jiang, C., Bosland, M. C., Lü, J., & Deng, Y. (2015) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-15-0236 · Cited by 21
Therapeutic strategies targeting cellular senescence for cancer and other diseases
Wang, X., Fukumoto, T., & Noma, K.-I. (2024) · The Journal of Biochemistry · doi:10.1093/jb/mvae015 · Cited by 29
Bitterman, P. B., & Polunovsky, V. A. (2012) · Cell Cycle · doi:10.4161/cc.11.6.19610 · Cited by 27
Khor, E.-S., & Wong, P. (2018) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2018.05.016 · Cited by 21
TBX2 controls a proproliferative gene expression program in melanoma
Lu, S., Louphrasitthiphol, P., Goradia, N., Lambert, J., Schmidt, J., Chauhan, J. S., Rughani, M. G., Larue, L., Wilmanns, M., & Goding, C. R. (2021) · Genes & Development · doi:10.1101/gad.348746.121 · Cited by 23
Yin, S., Dong, Y., Li, J., Lü, J., & Hu, H. (2011) · Molecular Carcinogenesis · doi:10.1002/mc.20743 · Cited by 20
Induction of senescence in primary glioblastoma cells by serum and TGFβ
Kumar, R., Gont, A., Perkins, T. J., Hanson, J. E. L., & Lorimer, I. A. J. (2017) · Scientific Reports · doi:10.1038/s41598-017-02380-1 · Cited by 28
Miyata, Y., Watanabe, S., Matsuo, T., Hayashi, T., Sakai, H., Xuan, J. W., Greer, P. A., & Kanda, S. (2011) · The Prostate · doi:10.1002/pros.21422 · Cited by 19
The PTEN and Myotubularin Phosphoinositide 3-Phosphatases: Linking Lipid Signalling to Human Disease
Davies, E. M., Sheffield, D. A., Tibarewal, P., Fedele, C. G., Mitchell, C. A., & Leslie, N. R. (2012) · Sub-cellular biochemistry/Subcellular biochemistry · doi:10.1007/978-94-007-3012-0_8 · Cited by 19
Cytokine-induced senescence for cancer surveillance
Wieder, T., Brenner, E., Braumüller, H., Bischof, O., & Röcken, M. (2017) · Cancer and Metastasis Reviews · doi:10.1007/s10555-017-9667-z · Cited by 20
Harnessing p53 for targeted cancer therapy: new advances and future directions
Andrysík, Z., & Espinosa, J. M. (2025) · Transcription · doi:10.1080/21541264.2025.2452711 · Cited by 22
Methodological aspects of the molecular and histological study of prostate cancer: Focus on PTEN
Ugalde‐Olano, A., Egia, A., Fernández‐Ruiz, S., Loizaga‐Iriarte, A., Zúñiga-García, P., Garcia, S., Royo, F., Lacasa-Viscasillas, I., Castro, E., Cortázar, A. R., et al. (2015) · Methods · doi:10.1016/j.ymeth.2015.02.005 · Cited by 19
Self-citationEwald, J. A., & Jarrard, D. F. (2012) · Translational Oncology · doi:10.1593/tlo.12181 · Cited by 22
Senescence, oxidative stress and mitochondria dysfunction
Zhu, M.-J., Wang, X., Shi, L., Liang, L., & Wang, Y. (2018) · Medical Research and Innovations · doi:10.15761/mri.1000149 · Cited by 20
Zhou, L. P., Yi, Y., Yuan, Q., Zhang, J., Li, Y., Wang, P., Xu, M., & Xie, S. (2018) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2018.09.016 · Cited by 17
PTEN, Longevity and Age-Related Diseases
Tait, I., Li, Y., & Lu, J. (2013) · Biomedicines · doi:10.3390/biomedicines1010017 · Cited by 18
Prognostic Significance of Biallelic Loss of PTEN in Clear Cell Renal Cell Carcinoma
Lee, H. J., Lee, H. Y., Lee, J. H., Lee, H., Kang, G., Song, J. S., Kang, J. K., & Kim, J. H. (2014) · The Journal of Urology · doi:10.1016/j.juro.2014.03.097 · Cited by 16
PTEN downregulation induces apoptosis and cell cycle arrest in uterine cervical cancer cells
Shin, J. H., Kim, S., & Yoon, J. S. (2021) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2021.10534 · Cited by 17
Senescence-associated lineage-aberrant plasticity evokes T-cell-mediated tumor control
Belenki, D., Richter‐Pechańska, P., Shao, Z., Bhattacharya, A., Lau, A., de Freitas, J. A. N. L. F., Kandler, G., Hick, T., Cai, X., Scharnagl, E., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-57429-x · Cited by 16
Sternberg, C., Raigel, M., Limberger, T., Trachtová, K., Schlederer, M., Lindner, D., Kodajova, P., Yang, J., Ziegler, R., Kalla, J., et al. (2024) · Molecular Cancer · doi:10.1186/s12943-024-02114-8 · Cited by 18
Implications of Cellular Aging in Cardiac Reprogramming
Passaro, F., & Testa, G. (2018) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2018.00043 · Cited by 15
Role of Senescence in Tumorigenesis and Anticancer Therapy
Stoczyńska-Fidelus, E., Węgierska, M., Kierasińska, A., Ciunowicz, D., & Rieske, P. (2022) · Journal of Oncology · doi:10.1155/2022/5969536 · Cited by 15
RBM4 regulates cellular senescence via miR1244/SERPINE1 axis
Wang, L., Zhang, X., Sheng, J., Chen, L., Zhi, L., Zheng, Q., Qi, Y., Wang, L., Zhang, J., Zhao, J., et al. (2023) · Cell Death and Disease · doi:10.1038/s41419-023-05563-z · Cited by 17
From man to mouse and back again: advances in defining tumor AKTivities in vivo
Restuccia, D. F., & Hemmings, B. A. (2010) · Disease Models & Mechanisms · doi:10.1242/dmm.004671 · Cited by 21
The Potent and Paradoxical Biology of Cellular Senescence in Cancer
Romesser, P. B., & Lowe, S. W. (2023) · Annual Review of Cancer Biology · doi:10.1146/annurev-cancerbio-061421-124434 · Cited by 16
Sen, A., Khan, S. A., Rossetti, S., Broege, A., MacNeil, I. A., DeLaForest, A., Molden, J. S., Davis, L., Iversrud, C., Seibel, M. I., et al. (2024) · Molecular Oncology · doi:10.1002/1878-0261.13703 · Cited by 18
Uzhachenko, R. V., Shimamoto, A., Chirwa, S., Ivanov, S. V., Ivanova, A. V., & Shanker, A. (2022) · Cancer Gene Therapy · doi:10.1038/s41417-022-00434-9 · Cited by 15
Cellular Senescence: Many Roads, One Final Destination
Saab, R. H. (2010) · The Scientific World JOURNAL · doi:10.1100/tsw.2010.68 · Cited by 16
Loss of circadian protein TIMELESS accelerates the progression of cellular senescence
Shen, X., Li, M., Mao, Z., & Yu, W. (2018) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2018.08.040 · Cited by 19
Targeting immunosenesence promotes clearance of senescent cells
Tizazu, A. M., Tessema, E. A., & Cexus, O. (2025) · Immunity & Ageing · doi:10.1186/s12979-025-00518-8 · Cited by 15
Chromatin-Associated Protein SIN3B Prevents Prostate Cancer Progression by Inducing Senescence
Bainor, A. J., Deng, F., Wang, Y., Lee, P., Cantor, D. J., Logan, S. K., & David, G. (2017) · Cancer Research · doi:10.1158/0008-5472.can-16-3410 · Cited by 14
Found in translation of mTOR signaling
Clohessy, J. G., Reschke, M., & Pandolfi, P. P. (2012) · Cell Research · doi:10.1038/cr.2012.85 · Cited by 13
Self-citationMatić, I., Revandkar, A., Chen, J., Bisio, A., Dall’Acqua, S., Cocetta, V., Brun, P., Mancino, G., Milanese, M., Mattei, M., et al. (2016) · Aging · doi:10.18632/aging.101076 · Cited by 14
Self-citationXie, B., Zhao, L., Chen, H., Jin, B., Mao, Z., & Yao, Z. (2013) · Biology of the Cell · doi:10.1111/boc.201200052 · Cited by 13
Senescence controls prostatic neoplasia driven by Pten loss
Parisotto, M., Grelet, É., Bizri, R. E., & METZGER, D. (2018) · Molecular & Cellular Oncology · doi:10.1080/23723556.2018.1511205 · Cited by 14
Wu, Z., Xia, M., Wang, J., Martínez-Aguilar, M., Buist‐Homan, M., & Moshage, H. J. (2024) · Cell Biochemistry and Function · doi:10.1002/cbf.4077 · Cited by 14
Bacca, L. F. G., Brandariz, J., Zacchi, F., Zivi, A., Mateo, J., & Labbé, D. P. (2025) · Gene · doi:10.1016/j.gene.2025.149774 · Cited by 16
RAS, cellular senescence and transformation: The BRCA1 DNA repair pathway at the crossroads
Tu, Z., Aird, K. M., & Zhang, R. (2012) · Small GTPases · doi:10.4161/sgtp.19884 · Cited by 12
Systematic transcriptomic analysis and temporal modelling of human fibroblast senescence
Scanlan, R.-L., Pease, L., O’Keefe, H., Guimera, A. M., Rasmussen, L. J., Wordsworth, J., & Shanley, D. P. (2024) · Frontiers in Aging · doi:10.3389/fragi.2024.1448543 · Cited by 11
Current and Emerging Therapies for Targeting the ERK1/2 & PI3K Pathways in Cancer
Abizadeh, E., Berglas, E., Abizadeh, A., Glatman, J., Lavi, A. B., Spivak, M., Sapir, T., & Shifteh, D. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26178696 · Cited by 17
Xie, W., Chu, Q., Brea, L. T., Zeng, G., Wang, Y., Lü, X., Zheng, M., Ley, C. R., Lei, Z., Shi, H., et al. (2026) · Oncogene · doi:10.1038/s41388-025-03662-z · Cited by 9
Lescarbeau, R. M., & Kaplan, D. L. (2014) · BMC Cancer · doi:10.1186/1471-2407-14-325 · Cited by 11
Cellular senescence: Silent operator and therapeutic target in cancer
Ramu, D., Teoh, W. S., Hirpara, J. L., & Pervaiz, S. (2021) · IUBMB Life · doi:10.1002/iub.2460 · Cited by 13
Nanomaterials intervene in cell senescence to reinforce cancer therapy
Sun, S., Yang, N., Nie, J., Yang, Z., Pei, Z., Ding, R., & Cheng, L. (2025) · Coordination Chemistry Reviews · doi:10.1016/j.ccr.2025.217012 · Cited by 10
Cellular Senescence and Senolytic Agents: Recent Updates on Their Role and Applications
Chandrakar, L., Ambatwar, R., & Khatik, G. L. (2023) · Current Topics in Medicinal Chemistry · doi:10.2174/0115680266273698231107110956 · Cited by 11
Senescent cell-derived vaccines: a new concept towards an immune response against cancer and aging?
Pessoa, J., Pereira, S. N., & de Jesus, B. B. (2024) · Aging · doi:10.18632/aging.205975 · Cited by 10
The Hippo Signaling Pathway Manipulates Cellular Senescence
Miyajima, C., Nagasaka, M., Aoki, H., Toriuchi, K., Yamanaka, S., Hashiguchi, S., Morishita, D., Aoyama, M., Hayashi, H., & Inoue, Y. (2024) · Cells · doi:10.3390/cells14010013 · Cited by 11
Tsc1 Regulates the Proliferation Capacity of Bone-Marrow Derived Mesenchymal Stem Cells
Guijarro, M. V., Danielson, L. S., Cañamero, M., Nawab, A., Abrahan, C. E., Hernando, E., & Palmer, G. D. (2020) · Cells · doi:10.3390/cells9092072 · Cited by 11
Tumor-infiltrating myeloid cells drive senescence evasion and chemoresistance in tumors
Mitri, D. D., Toso, A., & Alimonti, A. (2015) · OncoImmunology · doi:10.4161/2162402x.2014.988473 · Cited by 9
Self-citationIntegrating Senescence and Oxidative Stress in Cardiac Disease
Yun, H. R., Singh, M. K., Han, S., Ranbhise, J. S., Ha, J., Kim, S. S., & Kang, I. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms262411917 · Cited by 8
Deng, L., Mi, J., Ruan, X., Zhang, G., Pan, Y., & Wang, R. (2022) · Mediators of Inflammation · doi:10.1155/2022/4007469 · Cited by 8
Lu, X., Yuan, F., Qiao, L., Liu, Y., Gu, Q., Qi, X., Li, J., Li, D., & Liu, M. (2024) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.116099 · Cited by 8
Merolla, F. (2013) · Springer eBooks · doi:10.1007/978-94-007-7149-9_3 · Cited by 8
Lim, I. K., Choi, J.-A., Kim, E. Y., Kim, B. N., Jang, S., Ryu, M. S., & Shim, S. (2016) · Cellular Signalling · doi:10.1016/j.cellsig.2016.12.001 · Cited by 10
Taylor, W., Mathias, A., Ali, A., Ke, H., Stoynev, N., Shilkaitis, A. L., Green, A., Kiyokawa, H., & Christov, K. T. (2010) · BMC Cancer · doi:10.1186/1471-2407-10-541 · Cited by 8
Phosphatase-Independent Functions of the Tumor Suppressor PTEN
Papa, A., & Pandolfi, P. P. (2016) · Springer eBooks · doi:10.1007/978-1-4939-3649-6_9 · Cited by 8
Self-citationÁlvarez-Arzola, R., Bancaro, N., Lai, P., Attanasio, G., Pellegrini, L., Troiani, M., Colucci, M., Mosole, S., Pasquini, E., Alimonti, A., et al. (2023) · Cell Communication and Signaling · doi:10.1186/s12964-023-01095-3 · Cited by 9
Self-citationPreclinical and Coclinical Studies in Prostate Cancer
Chen, M., & Pandolfi, P. P. (2017) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a030544 · Cited by 10
Self-citationTissue-Based Diagnostic Biomarkers of Aggressive Variant Prostate Cancer: A Narrative Review
Kouroukli, O., Bravou, V., Giannitsas, K., & Tzelepi, V. (2024) · Cancers · doi:10.3390/cancers16040805 · Cited by 10
Llanos, S., & Garcia-Pedrero, J. M. (2016) · Molecular & Cellular Oncology · doi:10.1080/23723556.2016.1159275 · Cited by 7
Targeting senescent cells and tumor therapy (Review)
Wang, Z., Gao, J., Liu, H., Ohno, Y., & Xu, C. (2020) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2020.4705 · Cited by 14
Chen, J., Wu, L., Yang, H., Zhang, X., Xv, S., & Qian, Q. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.982033 · Cited by 10
Expansion of senescent megakaryocyte-lineage cells maintains CML cell leukemogenesis
Tanabe, Y., Kawamoto, S., Takaku, T., Morishita, S., Hirao, A., Komatsu, N., Hara, E., Mukaida, N., & Baba, T. (2020) · Blood Advances · doi:10.1182/bloodadvances.2020003117 · Cited by 10
To clear, or not to clear (senescent cells)? That is the question
Lujambio, A. (2016) · Inside the Cell · doi:10.1002/icl3.1046 · Cited by 11
Targeting senescent cell clearance: An approach to delay aging and age-associated disorders
Qiu, Z., Jia, J., Zou, H., Ao, Y., Liu, B., & Wang, Z. (2021) · Translational Medicine of Aging · doi:10.1016/j.tma.2020.12.001 · Cited by 7
Exploring a ‘Pro-Senescence’ Approach for Prostate Cancer Therapy by Targeting PTEN
Collado, M. (2010) · Future Oncology · doi:10.2217/fon.10.39 · Cited by 6
Pacifico, F., Crescenzi, E., & Leonardi, A. (2021) · Methods in molecular biology · doi:10.1007/978-1-0716-1669-7_12 · Cited by 6
PICS-ure This: Prosenescence Therapy?
Peeper, D. S. (2010) · Cancer Cell · doi:10.1016/j.ccr.2010.02.028 · Cited by 8
Cellular senescence in reproduction: a two-edged sword
Pretto, L., Nabinger, E., Filippi‐Chiela, E. C., & Fraga, L. R. (2024) · Biology of Reproduction · doi:10.1093/biolre/ioae025 · Cited by 5
The Inositol-5-Phosphatase SHIP1: Expression, Regulation and Role in Acute Lymphoblastic Leukemia
Ehm, P. A. H., & Jücker, M. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26146935 · Cited by 5
Ehm, P. A. H., Linnebacher, M., Block, A., Rehbach, C., & Jücker, M. (2023) · Cellular Signalling · doi:10.1016/j.cellsig.2023.110720 · Cited by 6
Abrogation of B-RafV600E induced senescence by FoxM1 expression
Choi, Y. W., Nam, G. E., Kim, Y. H., Yoon, J. E., Park, J. H., Kim, J.-H., Kang, S. Y., & Park, T. J. (2019) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2019.06.144 · Cited by 5
Is the Bench Getting Closer to the Bedside in the War on Cancer? A Quick Look at Prostate Cancer
Kypta, R. M., Unda, M., & Carracedo, A. (2012) · Frontiers in Endocrinology · doi:10.3389/fendo.2012.00053 · Cited by 6
Self-citationRuscetti, M. A., & Wu, H. (2013) · Springer eBooks · doi:10.1007/978-1-4614-6828-8_4 · Cited by 8
Ryan, J. J., Rehman, J., & Archer, S. L. (2011) · Circulation Research · doi:10.1161/circresaha.111.251579 · Cited by 5
Li, K., Guo, C., Li, R., Yao, Y., Qiang, M., Chen, Y., Tu, K., & Xu, Y. (2024) · Computers in Biology and Medicine · doi:10.1016/j.compbiomed.2024.109196 · Cited by 7
Santos‐Sousa, D., da Rosa, S., & Filippi‐Chiela, E. C. (2025) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2025.112052 · Cited by 9
Hellmold, D., Kubelt, C., Daunke, T., Beckinger, S., Janßen, O., Hauck, M., Schütt, F., Adelung, R., Lucius, R., Haag, J., et al. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24109075 · Cited by 4
Moscoso, C. G., & Steer, C. J. (2019) · Hepatic Medicine Evidence and Research · doi:10.2147/hmer.s213397 · Cited by 5
Narlik‐Grassow, M., Blanco‐Aparicio, C., Cecilia, Y., Perez, M., Muñoz-Galván, S., Marta, C., Renner, O., & Carnero, A. (2013) · PLoS ONE · doi:10.1371/annotation/1b8b6002-4e0f-4c5d-8ae8-fd45447b6149 · Cited by 4
Tumor Promoting Aspects of Senescence in Cancer Progression
Yang, Q., Xie, Y., & Miao, L. (2016) · Cancer Investigation · doi:10.1080/07357907.2016.1227443 · Cited by 4
Cellular Senescence and Tumor Promotion
Demaria, M. (2020) · Springer eBooks · doi:10.1007/978-3-319-57415-8_79 · Cited by 4
Zhao, H., Park, Y. M., Zheng, Y., Mao, Q., Collet, C., Hu, B., Zhou, T., Lin, L., Wong, S. K., Pan, Y., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.01.18.631624 · Cited by 3
Balancing the Edge: Phosphatases as Homeostatic Buffers of Oncogenic Kinase Signaling in Cancer
Ehm, P. A. H. (2026) · Kinases and Phosphatases · doi:10.3390/kinasesphosphatases4010004 · Cited by 2
Chemical intervention tools to probe phosphoinositide-dependent signalling
Woscholski, R. (2014) · Biochemical Society Transactions · doi:10.1042/bst20140186 · Cited by 2
Self-citationPro-senescence Therapy for Cancer: Time for the Clinic
Kalathur, M., Mitri, D. D., & Alimonti, A. (2014) · Springer eBooks · doi:10.1007/978-94-017-9421-3_8 · Cited by 2
Self-citationDifferent mutational characteristics of TSG in cell lines and surgical specimens
Stoczyńska-Fidelus, E., Bieńkowski, M., Pacholczyk, M., Winiecka-Klimek, M., Banaszczyk, M., Zięba, J., Bieniek, G., Piaskowski, S., & Rieske, P. (2014) · Tumor Biology · doi:10.1007/s13277-014-2444-5 · Cited by 2
Current Perspective on Dominant Negative Mutations: Trends, Scope and Relevance
(2020) · Biointerface Research in Applied Chemistry · doi:10.33263/briac114.1202012036 · Cited by 1
Ge, Y., Zhao, B., Li, M., Li, Z., Bai, S.-R., Zhang, Q., Wang, X., Wang, G., Cheng, J., & Wang, X. (2025) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2025.117404 · Cited by 1
Medkour, Y., Dufour, C. R., Han, L., Hutton, P., Farhat, M. H., Alfonso, A., Rambur, A., Vernier, M., & Giguère, V. (2025) · Oncogene · doi:10.1038/s41388-025-03623-6 · Cited by 2
Xiao, F., Hu, Q., Zeng, M., Guan, L., Liu, X., Yuan, Y., & Zhong, C. (2012) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2012.04.044 · Cited by 1
Comment limiter la progression des tumeurs prostatiques déficientes en PTEN ?
Grelet, É., Parisotto, M., & METZGER, D. (2018) · médecine/sciences · doi:10.1051/medsci/2018224 · Cited by 1
Metadata
- Authors
- Alimonti, A., Nardella, C., Chen, Z., Clohessy, J. G., Carracedo, A., Trotman, L. C., Cheng, K., Varmeh, S., Kozma, S. C., Thomas, G., Rosivatz, E., Woscholski, R., Cognetti, F., Scher, H. I., & Pandolfi, P. P.
- Affiliations
- Beth Israel Deaconess Medical Center (US)
- Memorial Sloan Kettering Cancer Center (US)
- University of Cincinnati (US)
- Imperial College London (GB)
- Instituto Nazionale Tumori Regina Elena (IT)
- Corresponding author
- Pandolfi, Pier Paolo
- ORCID
- Venue
- Journal of Clinical Investigation
- Published
- 2010-03-01
- Volume
- 120
- Issue
- 3
- Pages
- 681-693
- ISSN
- 0021-9738 (ISSN-L)
- PMC
- PMC2827955
- OpenAlex
- W2005250235
- Cited by
- 374
- References
- 46
- Citations by year
- 2026: 13 · 2025: 17 · 2024: 23 · 2023: 12 · 2022: 24 · 2021: 18 · 2020: 30 · 2019: 17 · 2018: 27 · 2017: 17 · 2016: 20 · 2015: 20 · 2014: 28 · 2013: 25 · 2012: 27
- FWCI
- 23.17
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Journal of Clinical Investigation (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Cold Spring Harbor Laboratory Institutional Repository (Cold Spring Harbor Laboratory) (acceptedVersion)
- Iris (University of Trento) (submittedVersion)
- Institutional Research Information System University of Turin (University of Turin) (submittedVersion)
- Dipòsit Digital de la Universitat de Barcelona (Universitat de Barcelona) (submittedVersion, public-domain)
- UCL Discovery (University College London) (submittedVersion)
- IRIS Research product catalog (Sapienza University of Rome) (submittedVersion)
- Padua Research Archive (University of Padova) (submittedVersion)
- Funders
- Prostate Cancer Foundation
- American-Italian Cancer Foundation
- Associazione Italiana di Oncologia Medica
- National Institutes of Health
- National Cancer Institute (R01CA137050)
- National Institute on Minority Health and Health Disparities (R01MD004038)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Telomeres, Telomerase, and Senescence
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Aging › Genetics, Aging, and Longevity in Model Organisms
- Keywords
- cellular senescence, PTEN inactivation, prostate cancer, tumor suppression, DNA damage response, non-proliferating cells, tumor xenografts
- MeSH terms
- Animals, Disease Models, Animal, DNA Damage, Embryo, Mammalian, Fibroblasts, Humans, Male, Neoplasm Transplantation, Prostatic Neoplasms, Protein Biosynthesis, Transplantation, Heterologous, Gene Expression Regulation, Neoplastic, Tumor Suppressor Protein p53, Cellular Senescence, Mice, Knockout, Cell Line, Tumor, Cell Proliferation, PTEN Phosphohydrolase, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.